http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2550312-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5014 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2004-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a1cc4ec7d55c029947b838bca55ae2a |
| publicationDate | 2005-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2550312-A1 |
| titleOfInvention | Retinal toxicity screening methods |
| abstract | The present invention relates to methods for characterizing a test agent using a fluorescently detectable .alpha.v.szlig.3 and .alpha.v.beta.5 integrin specific agent and a retinal pigment epithelial cell. The invention further relates to kits having a fluorescently detectable .alpha.v.beta.3 and .alpha.v.beta.5 integrin specific agent and a retinal pigment epithelial cell. |
| priorityDate | 2003-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.